BAFF-R CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAFF-R CAR-T Cells, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma [Phase 1]